After Years Of Setbacks, Marinus Closes In On Rare Epilepsy Opportunity

Ganaxolone Potential In Numerous Rare Conditions

After multiple failed attempts to treat rare conditions, Marinus is on the cusp of success with ganaxolone in genetic epilepsy, and has secured a new European partner in Orion.

Epilepsy brain
CDKL5 deficiency disorder (CDD) is a severe genetic form of epilepsy which can strike within the first three months of life. • Source: Alamy

More from Business

More from Scrip